Editorial: Neuroprotection and disease modification in Parkinson's disease: Volume II.
作者信息
Otero-Losada Matilde, Gubellini Paolo, Capani Francisco, Perez-Lloret Santiago
机构信息
Consejo Nacional de Investigaciones Cientificas y Tecnicas, Universidad Abierta Interamericana-Centro de Altos Estudios en Ciencias Humanas y de La Salud, UAI-CAECIHS CONICET, Buenos Aires, Argentina.
CNRS, IBDM, UMR7288, Aix-Marseille University, Marseille, France.
出版信息
Front Pharmacol. 2023 Jan 9;13:1121513. doi: 10.3389/fphar.2022.1121513. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Neuroprotection and disease modification in Parkinson's disease: Volume II.社论：帕金森病的神经保护与疾病修饰：第二卷
Front Pharmacol. 2023 Jan 9;13:1121513. doi: 10.3389/fphar.2022.1121513. eCollection 2022.
2
Editorial: Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease.社论：阿尔茨海默病和帕金森病的疾病修饰靶点及策略
Front Aging Neurosci. 2023 Jul 14;15:1247256. doi: 10.3389/fnagi.2023.1247256. eCollection 2023.
3
Editorial: Neuroprotection and Disease Modification in Parkinson's Disease.社论：帕金森病中的神经保护与疾病修饰
Front Pharmacol. 2021 Dec 8;12:813471. doi: 10.3389/fphar.2021.813471. eCollection 2021.
4
New hopes for disease modification in Parkinson's Disease.帕金森病治疗新希望：疾病修饰
Neuropharmacology. 2020 Jul;171:108085. doi: 10.1016/j.neuropharm.2020.108085. Epub 2020 Apr 13.
5
GardeninA confers neuroprotection against environmental toxin in a Drosophila model of Parkinson's disease.GardeninA 可在帕金森病的果蝇模型中提供针对环境毒素的神经保护作用。
Commun Biol. 2021 Feb 5;4(1):162. doi: 10.1038/s42003-021-01685-2.
6
Disease modification in Parkinson's disease.帕金森病的疾病修饰。
Drugs Aging. 2011 Aug 1;28(8):605-15. doi: 10.2165/11591320-000000000-00000.
7
Neuroprotection in Parkinson's disease: an elusive goal.帕金森病中的神经保护：一个难以实现的目标。
Semin Neurol. 2007 Apr;27(2):106-12. doi: 10.1055/s-2007-971168.
8
Therapies to Slow, Stop, or Reverse Parkinson's Disease.治疗帕金森病的方法：减缓、阻止或逆转。
J Parkinsons Dis. 2018;8(s1):S115-S121. doi: 10.3233/JPD-181481.
9
Neuroprotection and neurorestoration as experimental therapeutics for Parkinson's disease.神经保护和神经修复作为帕金森病的实验性治疗方法。
Exp Neurol. 2017 Dec;298(Pt B):137-147. doi: 10.1016/j.expneurol.2017.10.001. Epub 2017 Oct 5.
10
Recent Advances in Drug Repurposing for Parkinson's Disease.药物重用于帕金森病的最新进展。
Curr Med Chem. 2019;26(28):5340-5362. doi: 10.2174/0929867325666180719144850.
本文引用的文献
1
Opicapone as an add-on to levodopa for reducing end-of-dose motor fluctuations in Parkinson's disease: a systematic review and meta-analysis.奥匹卡朋作为左旋多巴的附加治疗，用于减少帕金森病的剂末运动波动：系统评价和荟萃分析。
J Comp Eff Res. 2022 Aug;11(12):889-904. doi: 10.2217/cer-2022-0031. Epub 2022 Jun 27.
2
Randomized, Controlled Study of Opicapone in Japanese Parkinson's Patients with Motor Fluctuations.随机、对照研究奥匹卡朋治疗日本有运动波动的帕金森病患者。
Mov Disord. 2021 Feb;36(2):415-423. doi: 10.1002/mds.28322. Epub 2020 Oct 19.
3
Vitis vinifera: An Alternative for the Prevention of Neurodegenerative Diseases.葡萄：预防神经退行性疾病的一种替代方法。
J Oleo Sci. 2020 Oct 7;69(10):1147-1161. doi: 10.5650/jos.ess20109. Epub 2020 Sep 10.
4
Ferroptosis and its potential role in the physiopathology of Parkinson's Disease.铁死亡及其在帕金森病病理生理学中的潜在作用。
Prog Neurobiol. 2021 Jan;196:101890. doi: 10.1016/j.pneurobio.2020.101890. Epub 2020 Jul 26.
5
Dopamine D1 Receptors Regulate Spines in Striatal Direct-Pathway and Indirect-Pathway Neurons.多巴胺 D1 受体调节纹状体直接通路和间接通路神经元的棘突。
Mov Disord. 2020 Oct;35(10):1810-1821. doi: 10.1002/mds.28174. Epub 2020 Jul 9.
6
Historical Perspective: Models of Parkinson's Disease.历史视角：帕金森病模型。
Int J Mol Sci. 2020 Apr 2;21(7):2464. doi: 10.3390/ijms21072464.
7
Role of TLR4 in the gut-brain axis in Parkinson's disease: a translational study from men to mice.TLR4 在帕金森病的肠-脑轴中的作用：从男性到小鼠的转化研究。
Gut. 2019 May;68(5):829-843. doi: 10.1136/gutjnl-2018-316844. Epub 2018 Dec 15.
8
Epigallocatechin-3-Gallate Protects and Prevents Paraquat-Induced Oxidative Stress and Neurodegeneration in Knockdown dj-1-β Drosophila melanogaster.表没食子儿茶素没食子酸酯可保护并预防敲低 dj-1-β 果蝇中的百草枯诱导的氧化应激和神经退行性变。
Neurotox Res. 2018 Oct;34(3):401-416. doi: 10.1007/s12640-018-9899-x. Epub 2018 Apr 17.
9
Low dose doxycycline decreases systemic inflammation and improves glycemic control, lipid profiles, and islet morphology and function in db/db mice.小剂量多西环素可降低 db/db 小鼠的全身炎症反应，改善血糖控制、血脂谱，并改善胰岛形态和功能。
Sci Rep. 2017 Oct 31;7(1):14707. doi: 10.1038/s41598-017-14408-7.
10
Neuroprotective and immunomodulatory effects of raloxifene in the myenteric plexus of a mouse model of Parkinson's disease.雷洛昔芬对帕金森病小鼠模型肌间神经丛的神经保护和免疫调节作用
Neurobiol Aging. 2016 Dec;48:61-71. doi: 10.1016/j.neurobiolaging.2016.08.004. Epub 2016 Aug 16.
Zotero 插件